Logo image of RELX

RELX PLC - SPON ADR (RELX) Stock Analyst Ratings

USA - New York Stock Exchange - NYSE:RELX - US7595301083 - ADR

43.14 USD
+0.79 (+1.87%)
Last: 1/9/2026, 8:22:37 PM
43.14 USD
0 (0%)
After Hours: 1/9/2026, 8:22:37 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to RELX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 55.17. This target is 27.89% above the current price.
RELX was analyzed by 23 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about RELX.
In the previous month the buy percentage consensus was at a similar level.
RELX was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
RELX Historical Analyst RatingsRELX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -109 -99 -89 -79 -69 -59 -49 -39 -29 -19 -9 10 20 30

Price Target & Forecast

Price Low Median Mean High 43.140.6259.2255.1774.36 - -98.57% 37.28% 27.89% 72.38%
RELX Current Analyst RatingRELX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-03-14 Barclays Upgrade Equal-Weight -> Overweight
2025-01-08 Redburn Atlantic Initiate Buy
2023-10-04 Goldman Sachs Upgrade Neutral -> Buy
2021-07-30 JP Morgan Cazenove Reiterate Overweight
2021-07-30 Barclays Reiterate Overweight
2021-07-05 Citigroup Reiterate Reiteration
2021-06-23 JP Morgan Cazenove Reiterate Overweight

RELX PLC - SPON ADR / RELX FAQ

What is the price target for RELX stock?

23 analysts have analysed RELX and the average price target is 55.17 USD. This implies a price increase of 27.89% is expected in the next year compared to the current price of 43.14.


What is the consensus rating for RELX PLC - SPON ADR (RELX) stock?

The consensus rating for RELX PLC - SPON ADR (RELX) is 82.6087 / 100 . This indicates that analysts generally have a positive outlook on the stock.